Article

Streptomyces axinellae sp. nov., isolated from the Mediterranean sponge Axinella polypoides (Porifera).

Research Center for Infectious Diseases, University of Würzburg, Röntgenring 11, D-97070 Würzburg, Germany.
International journal of systematic and evolutionary microbiology (impact factor: 2.27). 07/2009; 59(Pt 6):1433-7. DOI:10.1099/ijs.0.007856-0
Source: PubMed

ABSTRACT An actinomycete strain, isolated from the marine sponge Axinella polypoides collected from Banyuls-sur-Mer, France, was characterized using a polyphasic approach. Based on its chemotaxonomic and morphological characteristics, strain Pol001(T) belongs to the genus Streptomyces. The strain is characterized by ll-diaminopimelic acid in the cell wall, menaquinones MK-9(H(4), H(6), H(8)) and a DNA G+C content of 71.0 mol%. It forms a separate phyletic line based on phylogenetic analyses of the nearly complete 16S rRNA gene sequence. Strain Pol001(T) could be differentiated from other closely related Streptomyces species with validly published names by phenotypic and genotypic analysis. DNA-DNA hybridization between strain Pol001(T) and closely related reference strains further confirmed that strain Pol001(T) represents a novel taxon of the genus Streptomyces. Therefore, it is proposed that strain Pol001(T) represents a novel species in the genus Streptomyces, Streptomyces axinellae sp. nov.; the type strain is Pol001(T) (=DSM 41948(T) =CIP 109838(T)).

0 0
 · 
0 Bookmarks
 · 
44 Views
  • Source
    Article: Anti-parasitic compounds from Streptomyces sp. strains isolated from Mediterranean sponges.
    Sheila Marie Pimentel-Elardo, Svitlana Kozytska, Tim S Bugni, Chris M Ireland, Heidrun Moll, Ute Hentschel
    [show abstract] [hide abstract]
    ABSTRACT: Actinomycetes are prolific producers of pharmacologically important compounds accounting for about 70% of the naturally derived antibiotics that are currently in clinical use. In this study, we report on the isolation of Streptomyces sp. strains from Mediterranean sponges, on their secondary metabolite production and on their screening for anti-infective activities. Bioassay-guided isolation and purification yielded three previously known compounds namely, cyclic depsipeptide valinomycin, indolocarbazole alkaloid staurosporine and butenolide. This is the first report of the isolation of valinomycin from a marine source. These compounds exhibited novel anti-parasitic activities specifically against Leishmania major (valinomycin IC(50) < 0.11 microM; staurosporine IC(50) 5.30 microM) and Trypanosoma brucei brucei (valinomycin IC(50) 0.0032 microM; staurosporine IC(50) 0.022 microM; butenolide IC(50) 31.77 microM). These results underscore the potential of marine actinomycetes to produce bioactive compounds as well as the re-evaluation of previously known compounds for novel anti-infective activities.
    Marine Drugs 01/2010; 8(2):373-80. · 3.85 Impact Factor
  • Source
    Article: New tetromycin derivatives with anti-trypanosomal and protease inhibitory activities.
    Sheila M Pimentel-Elardo, Verena Buback, Tobias A M Gulder, Tim S Bugni, Jason Reppart, Gerhard Bringmann, Chris M Ireland, Tanja Schirmeister, Ute Hentschel
    [show abstract] [hide abstract]
    ABSTRACT: Four new tetromycin derivatives, tetromycins 1-4 and a previously known one, tetromycin B (5) were isolated from Streptomyces axinellae Pol001(T) cultivated from the Mediterranean sponge Axinella polypoides. Structures were assigned using extensive 1D and 2D NMR spectroscopy as well as HRESIMS analysis. The compounds were tested for antiparasitic activities against Leishmania major and Trypanosoma brucei, and for protease inhibition against several cysteine proteases such as falcipain, rhodesain, cathepsin L, cathepsin B, and viral proteases SARS-CoV M(pro), and PL(pro). The compounds showed antiparasitic activities against T. brucei and time-dependent inhibition of cathepsin L-like proteases with K(i) values in the low micromolar range.
    Marine Drugs 01/2011; 9(10):1682-97. · 3.85 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

actinomycete strain
 
cell wall
 
chemotaxonomic
 
complete 16S rRNA gene sequence
 
DNA G+C content
 
DNA-DNA hybridization
 
ll-diaminopimelic acid
 
marine sponge Axinella polypoides
 
names
 
novel species
 
novel taxon
 
polyphasic approach
 
related Streptomyces species
 
separate phyletic line
 
Streptomyces axinellae sp
 
type strain